Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minnesota, announced that it has secured market clearance for its diagnostic device. ProUroCare has developed an elasticity imaging technology that can be used to document abnormalities of the prostate. The technology would […]
Eden Prairie, Minnesota-based ProUroCare Medical Inc. is seeking $1 million, according to a filing with the U.S. Securities and Exchange Commission. ProUroCare has developed an elasticity imaging technology that can be used to document abnormalities of the prostate. The technology would serve as an adjunct to a digital rectal image, the current standard by which prostate […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Historically, a prostate cancer exam like the prostate cancer antigen (PSA) test or the digital rectal exam (DRE) has helped doctors identify whether patients have prostate cancer. But these screening tests are not always 100 percent accurate and may result in false positives, or need additional information for proper diagnosis and ongoing monitoring. ProUroCare Medical, […]